Suppr超能文献

致幻剂在头痛和慢性疼痛障碍治疗中的应用。

Psychedelics in the Treatment of Headache and Chronic Pain Disorders.

机构信息

Headache Center of Excellence, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.

Yale School of Medicine, New Haven, CT, USA.

出版信息

Curr Top Behav Neurosci. 2022;56:261-285. doi: 10.1007/7854_2022_365.

Abstract

The therapeutic potential of psychedelics in headache and chronic pain disorders is documented over decades of anecdotal and early investigational reports, which have paved the way for the first controlled studies of psilocybin and lysergic acid diethylamide (LSD) in these disorders. The reported lasting clinical effects after limited dosing with psychedelics present a novel means for disease management, but considerable further study will be required to address disease-specific treatments, uncover mechanism(s) of action, and verify safety. In this chapter, these topics are reviewed with particular attention to the neurobiological systems that offer potential sources of psychedelics' unique clinical effects in headache and pain.

摘要

迷幻剂在头痛和慢性疼痛障碍中的治疗潜力已有数十年的轶事和早期研究报告为证,这些报告为在这些障碍中首次进行 psilocybin 和麦角酸二乙基酰胺 (LSD) 的对照研究铺平了道路。在有限剂量使用迷幻剂后报告的持久临床效果为疾病管理提供了一种新方法,但需要进一步进行大量研究,以确定针对特定疾病的治疗方法、揭示作用机制,并验证安全性。在这一章中,特别关注提供迷幻剂在头痛和疼痛中独特临床效果潜在来源的神经生物学系统,对这些主题进行了回顾。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验